法国生物技术启动Generare筹集了5M欧元(5.5M美元),用于为微生物药物发现提供种子资金。 French biotech startup Generare raises €5M ($5.5M) in seed funding for microbial drug discovery.

法国生物技术创办公司Generare已获得500万欧元(550万美元)的种子资金,通过从微生物中探索天然化合物,加强其药物发现方法。 French biotech startup Generare has secured €5 million ($5.5 million) in seed funding to enhance its drug discovery methods by exploring natural compounds from microorganisms. 该公司成立于2022年10月,利用先进的遗传工程分析微生物DNA,在一年内确定1,000多个基因配方和100个新的抗生素分子。 Founded in October 2022, the company utilizes advanced genetic engineering to analyze microbial DNA, identifying over 1,000 genetic recipes and 100 novel antibiotic molecules within a year. Generare旨在对其创新技术进行专利认证,以加快寻找新的治疗药物。 Generare aims to patent its innovative techniques to expedite the search for new therapeutic drugs.